Figure 2.
Oxygenation capacity before and after local pulmonary human recombinant activated factor VII (rFVIIa) therapy. A significant improvement in PaO2/FiO2 (arterial oxygen pressure/inspiratory fractional oxygen content) ratio was observed after the hemostatic treatment (*p = 0.024, Wilcoxon signed paired rank test).